-
Product Insights
Acute Ischemic Stroke - Drugs In Development, 2024
Empower your strategies with our Acute Ischemic Stroke – Drugs In Development, 2024 report and make more profitable business decisions. An acute ischemic stroke occurs when a clot blocks a brain blood vessel, depriving it of oxygen. Symptoms, like numbness, confusion, or difficulty speaking, arise suddenly. Immediate medical attention is crucial. Treatment focuses on restoring blood flow, often with clot-dissolving drugs or a thrombectomy. Recovery varies; rehabilitation helps regain lost abilities. Lifestyle changes and medication may prevent future strokes. Early recognition...
-
Sector Analysis
Acute Ischemic Stroke (AIS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Acute Ischemic Stroke Competitive Analysis Report Overview AIS is a medical emergency caused by decreased blood flow to the brain, which results in damage to brain cells. It occurs when a blood vessel in the brain is blocked by a clot or mass, impeding blood flow to brain cells. The primary cause of ischemic stroke is atherosclerosis, the accumulation of fatty deposits (plaque) on vessel walls. These deposits can cause two types of obstruction, including cerebral thrombosis and cerebral embolism. Key Mechanisms...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.